<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T11:58:21Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10459.1/59055" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10459.1/59055</identifier><datestamp>2024-12-05T21:55:04Z</datestamp><setSpec>com_2072_3622</setSpec><setSpec>col_2072_479130</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Embryonic and postnatal development of GABA, calbindin, calretinin, and parvalbumin in the mouse claustral complex</dc:title>
   <dc:creator>Dávila, José Carlos</dc:creator>
   <dc:creator>Real, M. Ángeles</dc:creator>
   <dc:creator>Olmos, Luis</dc:creator>
   <dc:creator>Legaz, Isabel</dc:creator>
   <dc:creator>Medina Hernández, Loreta Mª</dc:creator>
   <dc:creator>Guirado, Salvador</dc:creator>
   <dc:subject>Calcium-binding proteins</dc:subject>
   <dc:subject>Dorsal claustrum</dc:subject>
   <dc:subject>Endopiriform nucleus</dc:subject>
   <dc:subject>Immunohistochemistry</dc:subject>
   <dcterms:abstract>We analyzed the development of immunoreactive expression patterns for the neurotransmitter&#xd;
 -aminobutyric acid (GABA) and the calcium-binding proteins calbindin, calretinin, and parvalbumin&#xd;
in the embryonic and postnatal mouse claustral complex. Each calcium-binding protein shows a&#xd;
different temporal and spatial pattern of development. Calbindin-positive cells start to be seen very&#xd;
early during embryogenesis and increase dramatically until birth, thus becoming the most abundant&#xd;
cell type during embryonic development, especially in the ventral pallial part of the claustrum. The&#xd;
distribution of calbindin neurons throughout the claustrum during embryonic development partly&#xd;
parallels that of GABA neurons, suggesting that at least part of the calbindin neurons of the claustral&#xd;
complex are GABAergic and originate in the subpallium. Parvalbumin cells, on the other hand, start&#xd;
to be seen only postnatally, and their number then increases while the density of calbindin neurons&#xd;
decreases. Based on calretinin expression in axons, the core/shell compartments of the dorsal claustrum&#xd;
start to be clearly seen at embryonic day 18.5 and may be related to the development of the&#xd;
thalamoclaustral input. Comparison with the expression of Cadherin 8, a marker of the developing&#xd;
dorsolateral claustrum, indicates that the core includes a central part of the dorsolateral claustrum,&#xd;
whereas the shell includes a peripheral area of the dorsolateral claustrum, plus the adjacent ventromedial&#xd;
claustrum. The present data on the spatiotemporal developmental patterns of several subtypes&#xd;
of GABAergic neurons in the claustral complex may help for future studies on temporal lobe&#xd;
epilepsies, which have been related to an alteration of the GABAergic activity.</dcterms:abstract>
   <dcterms:abstract>Grant sponsor: Spanish Direccio´n General de Investigacio´n-Fondo Europeo de Desarrollo Regional (FEDER); Grant number: BFI2003-06453-C02-01/02; Grant sponsor: Fondo de Investigaciones Sanitarias-FEDER; Grant number: 01/0057-02; Grant sponsor: Se´neca; Grant number: PB/50/FS/02; Grant sponsor: Red Centro de Investigacio´n de Enfermedades Neurolo´gicas-Nodo 318.</dcterms:abstract>
   <dcterms:dateAccepted>2024-12-05T21:55:03Z</dcterms:dateAccepted>
   <dcterms:available>2024-12-05T21:55:03Z</dcterms:available>
   <dcterms:created>2024-12-05T21:55:03Z</dcterms:created>
   <dcterms:issued>2017-01-20T10:15:10Z</dcterms:issued>
   <dcterms:issued>2025-01-01</dcterms:issued>
   <dcterms:issued>2005</dcterms:issued>
   <dc:type>article</dc:type>
   <dc:type>publishedVersion</dc:type>
   <dc:identifier>http://hdl.handle.net/10459.1/59055</dc:identifier>
   <dc:relation>MICYT/PN2000-2003/BFI2003-06453-C02-01/02</dc:relation>
   <dc:relation>Reproducció del document publicat a https://doi.org/10.1002/cne.20347</dc:relation>
   <dc:relation>The Journal of Comparative Neurology, 2005, vol. 481, núm. 1, p. 42–57</dc:relation>
   <dc:rights>(c) Wiley-Liss, Inc. 2005</dc:rights>
   <dc:rights>info:eu-repo/semantics/restrictedAccess</dc:rights>
   <dc:publisher>Wiley</dc:publisher>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>